rs7859993

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_133497.4(KCNV2):​c.915G>A​(p.Val305Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0466 in 1,613,348 control chromosomes in the GnomAD database, including 1,976 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 159 hom., cov: 33)
Exomes 𝑓: 0.047 ( 1817 hom. )

Consequence

KCNV2
NM_133497.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.345

Publications

5 publications found
Variant links:
Genes affected
KCNV2 (HGNC:19698): (potassium voltage-gated channel modifier subfamily V member 2) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium voltage-gated channel subfamily V. This member is identified as a 'silent subunit', and it does not form homomultimers, but forms heteromultimers with several other subfamily members. Through obligatory heteromerization, it exerts a function-altering effect on other potassium channel subunits. This protein is strongly expressed in pancreas and has a weaker expression in several other tissues. [provided by RefSeq, Jul 2008]
KCNV2 Gene-Disease associations (from GenCC):
  • cone dystrophy with supernormal rod response
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.031).
BP6
Variant 9-2718654-G-A is Benign according to our data. Variant chr9-2718654-G-A is described in ClinVar as Benign. ClinVar VariationId is 262363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.345 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0521 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNV2NM_133497.4 linkc.915G>A p.Val305Val synonymous_variant Exon 1 of 2 ENST00000382082.4 NP_598004.1 Q8TDN2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNV2ENST00000382082.4 linkc.915G>A p.Val305Val synonymous_variant Exon 1 of 2 1 NM_133497.4 ENSP00000371514.3 Q8TDN2
ENSG00000286670ENST00000768783.1 linkn.113+27644C>T intron_variant Intron 1 of 3
ENSG00000286670ENST00000768784.1 linkn.156+13291C>T intron_variant Intron 1 of 3
ENSG00000286670ENST00000768785.1 linkn.156+13291C>T intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0429
AC:
6535
AN:
152194
Hom.:
159
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0423
Gnomad AMI
AF:
0.0804
Gnomad AMR
AF:
0.0336
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0114
Gnomad FIN
AF:
0.0303
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0536
Gnomad OTH
AF:
0.0320
GnomAD2 exomes
AF:
0.0353
AC:
8802
AN:
249330
AF XY:
0.0346
show subpopulations
Gnomad AFR exome
AF:
0.0421
Gnomad AMR exome
AF:
0.0204
Gnomad ASJ exome
AF:
0.0301
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0314
Gnomad NFE exome
AF:
0.0520
Gnomad OTH exome
AF:
0.0334
GnomAD4 exome
AF:
0.0470
AC:
68719
AN:
1461036
Hom.:
1817
Cov.:
36
AF XY:
0.0459
AC XY:
33388
AN XY:
726876
show subpopulations
African (AFR)
AF:
0.0425
AC:
1423
AN:
33470
American (AMR)
AF:
0.0221
AC:
989
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0310
AC:
811
AN:
26122
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39692
South Asian (SAS)
AF:
0.0129
AC:
1117
AN:
86256
European-Finnish (FIN)
AF:
0.0331
AC:
1748
AN:
52786
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5766
European-Non Finnish (NFE)
AF:
0.0541
AC:
60157
AN:
1111852
Other (OTH)
AF:
0.0404
AC:
2442
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
4526
9052
13577
18103
22629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2186
4372
6558
8744
10930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0429
AC:
6538
AN:
152312
Hom.:
159
Cov.:
33
AF XY:
0.0404
AC XY:
3009
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0422
AC:
1756
AN:
41584
American (AMR)
AF:
0.0336
AC:
514
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0305
AC:
106
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.0114
AC:
55
AN:
4828
European-Finnish (FIN)
AF:
0.0303
AC:
322
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0536
AC:
3644
AN:
68020
Other (OTH)
AF:
0.0317
AC:
67
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
341
682
1022
1363
1704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0489
Hom.:
535
Bravo
AF:
0.0434
Asia WGS
AF:
0.00693
AC:
24
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone dystrophy with supernormal rod response Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.9
DANN
Benign
0.89
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7859993; hg19: chr9-2718654; COSMIC: COSV66056463; COSMIC: COSV66056463; API